ES537181A0 - Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos. - Google Patents

Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.

Info

Publication number
ES537181A0
ES537181A0 ES537181A ES537181A ES537181A0 ES 537181 A0 ES537181 A0 ES 537181A0 ES 537181 A ES537181 A ES 537181A ES 537181 A ES537181 A ES 537181A ES 537181 A0 ES537181 A0 ES 537181A0
Authority
ES
Spain
Prior art keywords
alpha
preparing
epoxi
ciano
hetero
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES537181A
Other languages
English (en)
Other versions
ES8603509A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sterwin AG
Original Assignee
Sterwin AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterwin AG filed Critical Sterwin AG
Publication of ES537181A0 publication Critical patent/ES537181A0/es
Publication of ES8603509A1 publication Critical patent/ES8603509A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C07J71/001—Oxiranes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Steroid Compounds (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES537181A 1983-10-29 1984-10-29 Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos. Expired ES8603509A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328929A GB8328929D0 (en) 1983-10-29 1983-10-29 Steroid compounds

Publications (2)

Publication Number Publication Date
ES537181A0 true ES537181A0 (es) 1985-12-16
ES8603509A1 ES8603509A1 (es) 1985-12-16

Family

ID=10550923

Family Applications (1)

Application Number Title Priority Date Filing Date
ES537181A Expired ES8603509A1 (es) 1983-10-29 1984-10-29 Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.

Country Status (11)

Country Link
US (1) US4605517A (es)
EP (1) EP0142309B1 (es)
AT (1) ATE49217T1 (es)
DE (1) DE3480929D1 (es)
DK (1) DK511184A (es)
ES (1) ES8603509A1 (es)
FI (1) FI81362C (es)
GB (2) GB8328929D0 (es)
GR (1) GR80795B (es)
NO (1) NO159385C (es)
PT (1) PT79423B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5995300A (ja) 1982-11-02 1984-06-01 スタ−リング・ドラッグ・インコ−ポレ−テッド コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物
US6458811B1 (en) 1996-03-26 2002-10-01 Eli Lilly And Company Benzothiophenes formulations containing same and methods
PT1200090E (pt) 1999-08-03 2013-11-25 Icos Corp Formulação farmacêutica à base de um beta-carbolina e seu uso para tratar a disfunção sexual.
GB2375958B (en) * 2001-04-09 2005-03-02 George Margetts The use of steroids to lower the levels of cortisol
MY143936A (en) * 2003-03-27 2011-07-29 Nycomed Gmbh Process for preparing crystalline ciclesonide with defined particle size
CN100404545C (zh) * 2003-03-27 2008-07-23 尼科梅德有限责任公司 具有规定粒径的结晶环缩松的制备方法
GB2400554B (en) * 2003-04-16 2007-04-18 George Margetts Treatment of angiotensin II-induced cardiovascular disease
GB2414238B (en) * 2004-05-22 2006-12-13 Stegram Pharmaceuticals Ltd Method for the preparation of trilostane
AU2007264418B2 (en) 2006-06-30 2012-05-03 Iceutica Pty Ltd Methods for the preparation of biologically active compounds in nanoparticulate form
EP3721008A4 (en) 2017-12-04 2021-09-08 Nanollose Limited PROCESS FOR THE PRODUCTION OF A VISCOSE SPINNING MATERIAL FROM MICROBIAL CELLULOSE

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB911815A (en) * 1958-03-24 1962-11-28 Sterling Drug Inc Steroid compounds and preparation thereof
NL104564C (es) * 1958-07-23
NO122525B (es) * 1960-11-23 1971-07-12 Merck & Co Inc
GB1123770A (en) * 1966-11-15 1968-08-14 Sterling Drug Inc 2-cyano-3-oxo-steroids
US4277409A (en) * 1977-03-18 1981-07-07 Roussel Uclaf Preparation of 9α-fluoro-16α-methyl-21-acetoxy-Δ1,4 -pregnadiene-11β-ol-3,20-dione
US4160027A (en) * 1977-12-20 1979-07-03 Sterling Drug Inc. Steroid cyanoketones and intermediates
US4391755A (en) * 1982-01-18 1983-07-05 E. R. Squibb & Sons, Inc. Steroid monohydrates, formulations containing same and method
JPS5995300A (ja) * 1982-11-02 1984-06-01 スタ−リング・ドラッグ・インコ−ポレ−テッド コントロ−ルされた粒度の２−シアノ−４，５−エポキシ−３−オキソ−ステロイド類およびそれらの組成物
US4459235A (en) * 1983-03-03 1984-07-10 G. D. Searle & Co. 2-Cyanosteroids

Also Published As

Publication number Publication date
DE3480929D1 (de) 1990-02-08
DK511184D0 (da) 1984-10-26
GB2148899A (en) 1985-06-05
GR80795B (en) 1985-03-01
PT79423A (en) 1984-11-01
FI844238L (fi) 1985-04-30
EP0142309A2 (en) 1985-05-22
EP0142309B1 (en) 1990-01-03
NO844300L (no) 1985-04-30
DK511184A (da) 1985-04-30
GB8328929D0 (en) 1983-11-30
GB2148899B (en) 1987-07-22
FI844238A0 (fi) 1984-10-29
EP0142309A3 (en) 1986-02-12
ATE49217T1 (de) 1990-01-15
NO159385C (no) 1988-12-21
GB8427300D0 (en) 1984-12-05
ES8603509A1 (es) 1985-12-16
PT79423B (en) 1986-11-13
FI81362B (fi) 1990-06-29
NO159385B (no) 1988-09-12
US4605517A (en) 1986-08-12
FI81362C (fi) 1990-10-10

Similar Documents

Publication Publication Date Title
ES537181A0 (es) Procedimiento para preparar compuestos esteroides 2-alfa-ciano-4 alfa,5 alfa epoxi-3-oxo y (2,3-d) hetero-sustituidos.
NO822222L (no) Fremgangsmaate for fremstilling av pyrrolidinderivater
SE7603951L (sv) Forfarande for framstellning av 7-alfa-(4-hydroci-1,5-nafthydrin-3karbonamido)alfa-fenylacetamido-cefalosporinderivat
IE41394L (en) Benzimidazole derivatives
ES432790A1 (es) Un metodo para producir derivados del acido 2-cloropropioni-co.
KR950000702A (ko) 결정성 β- 락탐 일수화물의 제조방법
ES419739A1 (es) Procedimiento para la preparacion de 2-arilamino-imidazoli-nas (2) sustituidas.
ES416476A1 (es) Procedimiento para la transformacion de compuestos s-oxido de penicilina en compuestos de desacetoxicefalosporina.
ES416311A1 (es) Un procedimiento de preparacion de esteres dialquilaminoal-quilicos del acido 2-(6-metoxi-2-naftil) propionico.
KR850004758A (ko) 피라졸로 피리딘 유도체의 제법
ES2002111A6 (es) Un procedimiento para preparar pirimido-(2,1-b)-benzotiazoles
ES8704163A1 (es) Un procedimiento para preparar derivados de cefem.
ES8207546A1 (es) Un procedimiento para preparar nuevos compuestos de cefem
JPS5653685A (en) Production of cephalosporin derivative
ES384599A1 (es) Procedimiento para la preparacion de nuevos derivados basi-cos de pirrol.
ES8606273A1 (es) Un procedimiento para la preparacion de compuestos de 2- oxindol
GB1456180A (en) Imidazolyl-1-ether ketone derivative and its salts a process for their preparation and their use as medicaments
ES451242A1 (es) Un procedimiento para la preparacion de imidazoles.
ES422343A1 (es) Un procedimiento para preparar acidos metil-2 o 3-cefem-4- carboxilicos 3-sustituidos.
ES421940A1 (es) Procedimiento para la preparacion de nuevos derivados de 2-aminometil-4, 6-dihalogenofenol.
ES366648A1 (es) Procedimiento de preparacion de nuevas morfantridinas.
JPS54125681A (en) 5-substituted picolinic acid, its preparation, and hypotensive agent containing the same
ES8301223A1 (es) Procedimiento para la preparacion de derivados de 2-(4-hi- droxialquil-1-piperacinil)-2,4,6-cicloheptatrien-1-ona
SE8204765D0 (sv) 2-(o-carboxyphenylamino)-6h-pyrimido(2,1-b)-quina-zolone-6 and derivatives thereof, method of producing and application
ES366649A1 (es) Procedimiento de preparacion de nuevas morfantridinas.

Legal Events

Date Code Title Description
MM4A Patent lapsed

Effective date: 19960401